Ari Landon, PhD, MBA, is Head of Venture Ecosystem for One Health Studio at Alloy Partners. He's an executive scientist who has focused his career on novel and disruptive therapeutic and device development, with experience across private and public companies and non-profit organizations. At Rafael Holdings, a publicly traded pharmaceutical and medical device investment company, he led scientific diligence for acquisitions as Head of Search and Evaluation and sat on the investment committee. He also served as Division President of Rafael Medical Devices, taking an orthopedic device from concept through FDA submission.

Ari co-founded the Barer Institute and later led it as Executive Director and COO, managing a team of about 50 scientists developing small molecule therapies for aggressive cancer. Most recently, as Chief Scientific Business Development Officer at the Indiana Biosciences Research Institute (IBRI), he built strategic partnerships with Eli Lilly, Elanco, and MBX, and spearheaded a for-profit subsidiary focused on company creation. He's also been VP of Life Sciences at Elevate Ventures, mentoring and funding life science companies from seed onward.

At One Health Studio, Ari is excited to cultivate a network of customers and investors for the studio's diverse portfolio of life science companies.